Aurobindo Pharma was up 9% at Rs 826, surging 22% in past three trading days after the company on Thursday announced the acquisition of Sandoz's generic business in the US for $900 million.
from Latest News https://ift.tt/2NSDGGl
Friday, 7 September 2018
Aurobindo Pharma, Glenmark Pharma hit 52-week highs
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment